Amnio Technology News

Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers

Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers

Phoenix, October 20, 2020 Amnio Technology, LLC, a global leader in the development and distribution of amniotic tissue allografts, is announcing today that it has received authorization from FDA to  proceed with a Phase 2 clinical trial under an Investigational...

Amnio Technology announces national launch of PalinGen® InovōFlo™ to supplement tissue for protection, cushioning and lubrication

Amnio Technology announces national launch of PalinGen® InovōFlo™ to supplement tissue for protection, cushioning and lubrication

PHOENIX, Sept. 5, 2017 /PRNewswire/ -- Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, announced today the expansion of its product line with the launch of PalinGen® InovōFlo™. PalinGen®...

Amnio Technology News

Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers

Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers

Phoenix, October 20, 2020 Amnio Technology, LLC, a global leader in the development and distribution of amniotic tissue allografts, is announcing today that it has received authorization from FDA to  proceed with a Phase 2 clinical trial under an Investigational...

Amnio Technology announces national launch of PalinGen® InovōFlo™ to supplement tissue for protection, cushioning and lubrication

Amnio Technology announces national launch of PalinGen® InovōFlo™ to supplement tissue for protection, cushioning and lubrication

PHOENIX, Sept. 5, 2017 /PRNewswire/ -- Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, announced today the expansion of its product line with the launch of PalinGen® InovōFlo™. PalinGen®...

Call Now Button